Results of in vitro and in vivo studies have shown that gentamycin administration to mdx mice, an animal model of DMD harboring a nonsense mutation in exon 23 of Dmd [12], can restore dystrophin expression and resistance to contraction-induced muscle injury [13]. The gene discussed is DMD; the disease is Duchenne muscular dystrophy.